21 unknown. 21 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 21 | Unknown 21 |
| Phase 2 | 4 | Unknown 4 |
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial Anti-Xa Guided Dosing of Low Molecular Weight Heparin, Standard of Care Dosing - Venous Thromboembolism (VTE), Trauma Related Injuries | Phase 2 / Phase 3 | Unknown | Alexandre Tran | 150 | 2025-01-01 | 2024-10-28 |
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer Innohep, Chemotherapy: Gemcitabine + Nab-Paclitaxel - Pancreatic Cancer, Thromboembolism | Phase 3 | Unknown | Michalis Karamouzis | 450 | 2022-02-10 | 2022-03-29 |
| Dabigatran Versus Apixaban in Cerebral Venous Thrombosis Dabigatran Etexilate 150mg, Apixaban 5MG - Cerebral Venous Sinus Thrombosis | Phase 3 | Unknown | Kafrelsheikh University | 200 | 2021-08-01 | 2024-08-13 |
| Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis Apixaban 5MG, Rivaroxaban 20 MG Oral Tablet - Cerebral Venous Thrombosis | Phase 3 | Unknown | Kafrelsheikh University | 200 | 2021-08-01 | 2024-08-19 |
| Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin Rivaroxaban, Enoxaparin - Cancer, Rivaroxaban | Phase 3 | Unknown | André Luiz Malavasi Longo de Oliveira | 440 | 2020-10-22 | 2021-08-10 |
| Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters Rivaroxaban, Warfarin, Nadroparin - Venous Thromboembolism | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2020-05-08 | 2024-04-18 |
| Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. Debriefing and educative components, Without debriefing and educative components - Venous Thromboembolism | Phase 3 | Unknown | University Hospital, Brest | 150 | 2019-12-27 | 2020-12-02 |
| Tecarfarin Anti-Coagulation Trial (TACT) Warfarin, tecarfarin - Thromboembolism, Thrombosis | Phase 3 | Unknown | Espero Biopharma | 1000 | 2018-06-01 | 2018-01-25 |
| The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis Dabigatran etexilate, Warfarin - Cerebral Venous Thrombosis | Phase 3 | Unknown | Capital Medical University | 80 | 2017-10-30 | 2017-11-22 |
| A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism Dabigatran etexilate, Tinzaparin - Venous Thromboembolism, Deep Vein Thrombosis | Phase 3 | Unknown | The University of Hong Kong | 99 | 2017-09-01 | 2019-04-17 |
| Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI Preloading before TAVI, Postloading after TAVI - Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement | Phase 3 | Unknown | Charite University, Berlin, Germany | 200 | 2017-03-01 | 2016-12-28 |
| Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose Enoxaparin - Venous Thromboembolism | Phase 3 | Unknown | Hamilton Health Sciences Corporation | 20 | 2016-03-01 | 2021-10-15 |
| Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection Concomitant Tumescent Antibiotic Delivery & IV Delivery, Subcutaneous Tumescent Infiltration, cecefazolin and metronidazole (in a dilute solution of tumescent lidocaine, epinephrin and sodium bicarbonate in 0.9% physiologic saline) - Surgical Site Infections, Venous Thromboembolism | Phase 2 / Phase 3 | Unknown | Klein, Jeffrey A., M.D. | 400 | 2015-10-01 | 2015-07-21 |
| Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk dabigatran, placebo - Atrial Fibrillation, Thromboembolism | Phase 3 | Unknown | Korea University | 464 | 2014-12-01 | 2014-12-10 |
| Optimal Prophylactic Method of Venous Thromboembolism (VTE) low molecular weight heparin - Venous Thromboembolism | Phase 3 | Unknown | The Catholic University of Korea | 682 | 2011-10-01 | 2017-02-07 |
| Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients heparin sodium - Hipolabor, Heparin sodium - APP - Venous Thromboembolism | Phase 2 / Phase 3 | Unknown | Azidus Brasil | 140 | 2010-05-01 | 2010-10-27 |
| D-Dimer Guided Oral Anticoagulant Treatment (OAT) Phenprocoumon, Warfarin-Natrium - Deep Venous Thrombosis | Phase 3 | Unknown | University Hospital, Bonn | 300 | 2008-02-01 | 2009-05-08 |
| Dalteparin in Preventing Blood Clots in Patients With Lung Cancer dalteparin, quality-of-life assessment - Lung Cancer, Thromboembolism | Phase 3 | Unknown | Velindre NHS Trust | 2200 | 2007-08-01 | 2011-08-08 |
| PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin. Dalteparin, Placebo - Stroke | Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1473 | 2006-12-01 | 2020-02-19 |
| Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion transcranial ultrasound in patients treated with iv t-PA - Intracranial Embolism, Thrombosis | Phase 3 | Unknown | University of Zurich | 400 | 2006-06-01 | 2007-04-27 |
Showing 20 of 21. Sign in to see all of them.
Venous Thromboembolism (11) · Intracranial Thrombosis (3) · Thrombosis (3) · Venous Thrombosis (3) · Atrial Fibrillation (2) · Intracranial Embolism (2) · Pulmonary Embolism (2) · Aortic Valve Stenosis (1) · Atherosclerosis (1) · Carcinoma, Non-Small-Cell Lung (1) · Infarction, Middle Cerebral Artery (1) · Infections (1) · Intracranial Embolism and Thrombosis (1) · Lung Neoplasms (1)
Cardiovascular Diseases (21) · Embolism and Thrombosis (21) · Vascular Diseases (21) · Brain Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Nervous System Diseases (6) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Intracranial Embolism and Thrombosis (4) · Heart Diseases (3) · Lung Diseases (3) · Neoplasms (3) · Neoplasms by Site (3)
Dabigatran (4) · Rivaroxaban (3) · Warfarin (3) · Dalteparin (2) · Enoxaparin (2) · Tinzaparin (2) · apixaban (2) · 130-nm albumin-bound paclitaxel (1) · Argininosuccinate Synthase (1) · Aspirin (1) · Clopidogrel (1) · Epinephrine (1) · Heparin, Low-Molecular-Weight (1) · Metronidazole (1) · Nadroparin (1)
Kafrelsheikh University (2) · Alexandre Tran (1) · André Luiz Malavasi Longo de Oliveira (1) · Azidus Brasil (1) · Capital Medical University (1) · Charite University, Berlin, Germany (1) · Espero Biopharma (1) · Hamilton Health Sciences Corporation (1) · Klein, Jeffrey A., M.D. (1) · Korea University (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Michalis Karamouzis (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · The Catholic University of Korea (1) · The University of Hong Kong (1)
Brazil (2) · Canada (2) · China (2) · Egypt (2) · Austria (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · India (1) · Italy (1) · South Korea (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Alexandre Tran, MD, MSc, FRCSC (1) · Bernd Poetzsch, Professor (1) · Cecilia Becattini, MD (1) · Eduardo Ramacciotti, MD, PhD (1) · Fergus Macbeth, MD (1) · Giancarlo Agnelli, MD (1) · Gloria Hwang, MBBS (1) · Kyo Young Song, M.D. (1) · Marc Carrier, MD, MSc, FRCPC (1) · Michael J Kovacs, MD, FRCPC (1) · Mihir Bhatt, MD (1) · Paolo Prandoni, PhD (1) · Ralf W Baumgartner, MD (1) · Zhejie Liu (1)
PMID 31867054, PMID 18190818, PMID 19807917, PMID 22621626, PMID 25012265, PMID 30027281, PMID 33337539, PMID 34108229, PMID 34622445, PMID 34697109, PMID 34878173, PMID 35089599, PMID 35876829